Clinical Trial Update: A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing safety and pharmacokinetic assessment of RO7795081 and its effect on the metabolism of pitavastatin and rosuvastatin in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RO7795081

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Overweight, Obesity | Phase 1 | Status: RECRUITING